Navigation Links
Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
Date:8/15/2011

PHILADELPHIA A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.

In a retrospective study of 98 patients with advanced Sezary Syndrome treated over a 25 year time span at the Hospital of the University of Pennsylvania patients treated with combination therapy experienced a higher overall response rate compared to previous studies (74.4 percent vs. 63 percent), and a higher complete response rate (30 percent vs. 20 percent). The 5-year overall survival rate was also higher than previously reported (55 percent vs. 30 percent). Researchers concluded that combination immunotherapy is more effective than a single treatment.

"This rare disease, if caught soon enough, may no longer be fatal, thanks to advances in treatment and our understanding of the disease," said Alain Rook, MD, professor of Dermatology and senior author of the study, which appears online in the Archives of Dermatology, a JAMA/Archives journal. "In addition, our improved understanding of prognostic factors will help us tailor treatments for each patient, based on the aggressiveness of their disease, and better predict individual patient outcomes."

Sezary Syndrome is difficult to treat and has had a poor prognosis. In patients with Sezary Syndrome, malignant T-cells proliferate in the blood, while skin on the surface becomes inflamed, scaly and extremely itchy and doesn't respond to typical skin treatments. The lymphoma circulates in the blood, and tumors spread to the lymph nodes and internal organs. Typically, in the past, as few as 30 percent of patients survived 5 years with Sezary Syndrome; on average, patients survived 40 months after diagnosis.

In the Penn study, patients with advanced Sezary Syndrome received multimodalit
'/>"/>

Contact: Kim Menard
kim.menard@uphs.upenn.edu
215-662-6183
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Different subtypes of triple-negative breast cancer respond to different therapies
2. Treatment for Abuse of Anti-Anxiety Drugs Tripled Over 10 Years
3. Gene expression predicts chemotherapy sensitivity of triple-negative breast cancer
4. Nationwide utilization of virtual colonoscopy triples, study suggests
5. Philanthropic pledge triples funds for TGen ovarian cancer research
6. Multiple childbirth linked to increased risk of rare, aggressive triple-negative breast cancer
7. Genetic trait could triple odds of whites susceptibility to heavy cocaine abuse
8. Trio of drugs may combat triple negative breast cancer
9. Scientists identify potential new target for treating triple negative breast cancer
10. MRI, CT Scans for ER Patients Triple Over Decade
11. Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... The ... Information Management has been granted continued accreditation based on a successfully completed ... “Achieving and maintaining this accreditation takes the involvement and dedication of each ...
(Date:9/1/2015)... , ... September 01, 2015 , ... With former IBMers ... and Math) disciplines since its inception more than 35 years ago. A pilot program ... and their teachers - and, not just those intent on pursuing careers in these ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent ... and women for 19 years and found that, among those who had a stroke, ... The report is part of the September 2015 issue of “Natural Insights for Well ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based ... dystrophy (FSHD), will be the beneficiary of a collection of fundraising events this fall. ... awareness of the FSH Society and further FSHD research. , The list ...
(Date:9/1/2015)... ... ... SC&H Group, a leading audit, tax, and consulting firm, received multiple honors ... firm in the U.S., as well as being ranked a Top 100 Accounting Firm. ... selected exclusively on performance in specific areas of financial and operational management. SC&H ...
Breaking Medicine News(10 mins):Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2
... 26 (HealthDay News) -- Women should be screened for ... women in the United States -- during routine visits ... Researchers from Mount Sinai Medical Center in ... visits to obstetrician/gynecologists could help identify women with undetected ...
... the Society of Interventional Radiology,s 37th Annual Scientific Meeting ... end of the tunnel for individuals with inoperable locally ... electroporation or IRE uses microsecond electrical pulses to force ... delicate network of blood vessels of the pancreas. ...
... major clinical trial to investigate whether eliminating a common stomach ... patients. The Helicobacter Eradication Aspirin Trial (HEAT) ... pylori in the gut of patients taking up to ... developing a stomach ulcer and dangerous associated bleeding a ...
... study has found that very few young women with cancer ... Also, certain groups of young women are more likely to ... , a peer-reviewed journal of the American Cancer Society, the ... fertility preservation in reproductive-aged women diagnosed with cancer. More ...
... Netherlands have found that the menopausal symptoms caused ... women with breast cancer can be ameliorated considerably ... and physical exercise (PE). These interventions can be ... hot flushes, night sweats, vaginal dryness, weight gain, ...
... -- Two long-term studies from the Netherlands suggest that ... of the longest national breast cancer screening programs in ... and caused limited harm, such as false-positive results and ... Another study found that regular mammography screening helped save ...
Cached Medicine News:Health News:Ob/Gyn Visit a Good Time to Screen for Heart Disease: Study 2Health News:Electrical pulse treatment gives pancreatic cancer patients new hope 2Health News:Can eradicating a common stomach bug make taking aspirin safer? 2Health News:Few young women with cancer take steps to preserve fertility during treatments 2Health News:Non-drug treatments help alleviate symptoms of treatment-induced menopause in breast cancer patients 2Health News:Non-drug treatments help alleviate symptoms of treatment-induced menopause in breast cancer patients 3Health News:Two Studies Find Routine Mammography Saves Lives 2Health News:Two Studies Find Routine Mammography Saves Lives 3Health News:Two Studies Find Routine Mammography Saves Lives 4
(Date:9/1/2015)... 1, 2015 Egalet Corporation (Nasdaq: ... company focused on discovering, developing, and commercializing innovative ...  presenting scientific data on SPRIX ® (ketorolac ... morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, ... 2015 to be held September 8 to ...
(Date:9/1/2015)...  Abbott (NYSE: ABT ) announced today positive one-year ... comparing the safety and effectiveness of Abbott,s fully dissolving ... market-leading, permanent drug eluting stent. The trial was conducted ... and enrolled 400 people with coronary artery disease, the ... be featured at a late-breaking session today at ESC ...
(Date:9/1/2015)... LAVAL, Quebec , Sept. 1, 2015 /PRNewswire/ ... and TSX: VRX) today announced that its affiliate ... under which Valeant was granted an exclusive license ... Brodalumab is an IL-17 receptor monoclonal antibody in ... psoriatic arthritis. Under the agreement, Valeant will hold ...
Breaking Medicine Technology:Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
... Carol Keehan, DC, president and chief executive officer of ... issued the following statement. The Catholic Health ... for her intelligent and courageous decision to prevent very ... hormone contained in the drug known as Plan B. ...
... The Dr. Paul Janssen Award for Biomedical ... This prestigious award recognizes individuals whose scientific research ... significant transformational contributions toward the improvement of human ... will be accepted until February 15, 2012, for ...
Cached Medicine Technology:Catholic Health Association Applauds HHS Decision on Plan B 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 4
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... Hoffmann® II Hybrid External Fixation System ... generation in hybrid fixation. It incorporates ... and is designed to offer speed ... patented Hoffmann® snap-fit technology. , ,Using ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
Medicine Products: